SRGA Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (4 Apr 2024 @ 16:00):

Stats
Today's Volume	8.72M
Average Volume	0.00
Market Cap	1.68M
EPS	$0 ( 2024-03-28 )
Next earnings date	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0200
ATR14	$0.126 (68.89%)

Insider Trading

Date	Person	Action	Amount	type
2023-09-15	Lyle David	Sell	1 329	Common Stock
2023-09-01	Amoruso Paolo	Sell	2 191	Common Stock
2023-08-15	Thunander Christopher	Sell	2 295	Common Stock
2023-08-15	Sangiorgio Enrico	Sell	5 541	Common Stock
2023-08-15	Rich Terry M.	Sell	8 821	Common Stock

INSIDER POWER
39.80
Last 99 transactions
Buy: 15 096 749 \| Sell: 83 212

Volume Correlation

Long: -0.43 (neutral)

Short: 0.59 (weak)

Signal:(29.972) Neutral

Surgalign Holdings, Inc. Correlation

10 Most Positive Correlations
GAINL	0.914
ISNS	0.892
LCY	0.843
TDAC	0.836
APOP	0.826

10 Most Negative Correlations
BOCH	-0.893
SHSP	-0.86

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Surgalign Holdings, Inc. Correlation - Currency/Commodity

-0.76
( moderate negative )

-0.68
( moderate negative )

-0.75
( moderate negative )

0.67
( moderate )

-0.45
( neutral )

0.40
( neutral )

Surgalign Holdings, Inc. Financials

Annual	2022
Revenue:	$81.98M
Gross Profit:	$40.29M (49.14 %)
EPS:	$-8.33

Q1	2023
Revenue:	$16.75M
Gross Profit:	$10.67M (63.73 %)
EPS:	$0.510

Q4	2022
Revenue:	$20.57M
Gross Profit:	$-2.81M (-13.65 %)
EPS:	$-5.77

Q3	2022
Revenue:	$20.18M
Gross Profit:	$14.69M (72.81 %)
EPS:	$-1.460

Financial Reports:

No articles found.

Surgalign Holdings, Inc.

Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.